Travere Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Travere Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Travere Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -56.1 %, a 391% decline year-over-year.
  • Travere Therapeutics, Inc. annual Return On Assets for 2023 was -14.1 %, a 62% increase from 2022.
  • Travere Therapeutics, Inc. annual Return On Assets for 2022 was -37.1 %, a 57.5% decline from 2021.
  • Travere Therapeutics, Inc. annual Return On Assets for 2021 was -23.5 %, a 11.4% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -14.1 +23 +62% Jan 1, 2023 Dec 31, 2023
2022 -37.1 -13.5 -57.5% Jan 1, 2022 Dec 31, 2022
2021 -23.5 +3.04 +11.4% Jan 1, 2021 Dec 31, 2021
2020 -26.6 -3.45 -14.9% Jan 1, 2020 Dec 31, 2020
2019 -23.1 -6.12 -36% Jan 1, 2019 Dec 31, 2019
2018 -17 -5.38 -46.4% Jan 1, 2018 Dec 31, 2018
2017 -11.6 -2.48 -27.2% Jan 1, 2017 Dec 31, 2017
2016 -9.13 -34.3 -136% Jan 1, 2016 Dec 31, 2016
2015 25.1 +109 Jan 1, 2015 Dec 31, 2015
2014 -83.6 +196 +70.1% Jan 1, 2014 Dec 31, 2014
2013 -280 +4.77K +94.5% Jan 1, 2013 Dec 31, 2013
2012 -5.05K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.